Core Component B, the Signaling and Motility Assays Core, will provide the expertise, protocols, analysis and interpretation of in vitro assays that examine the individual behavior, and interaction of tumor and stromal cells. The Core performs assays examining two-dimensional motile cell behavior, three-dimensional invasion, angiogenesis and transendothelial migration. These assays permit a comprehensive examination of cell behavior during chemotaxis, and provide a rapid and complete analysis of the invasive capabilities of a given cell type prior to costly and time-consuming animal studies. Moreover these in vitro assays support and complement the in vivo studies provided by the Intravital Imaging, Invasive Cell Collection and Expression Profiling Core (Core A). Core B will also act as a liaison for the use of unique protein biosensors and for assays examining invadopod formation so that the application of these technologies is uniform amongst the projects. The in vitro assays supported by Core B provide much needed information about cellular behavior and mechanism during tumor cell invasion and intravasation.The leading cause of death in cancer patients is the ability of tumor cells to leave the primary tumor, travel to distant sites within the body and form secondary tumors. The assays provided by this Core specifically examine the individual behavior and interaction of tumor and stromal cells, and will provide the foundation for understanding the mechanisms regulating tumor cell motility and invasion.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA100324-09
Application #
8302463
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2011-06-01
Budget End
2012-05-31
Support Year
9
Fiscal Year
2011
Total Cost
$112,519
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Meirson, Tomer; Genna, Alessandro; Lukic, Nikola et al. (2018) Targeting invadopodia-mediated breast cancer metastasis by using ABL kinase inhibitors. Oncotarget 9:22158-22183
Dulyaninova, Natalya G; Ruiz, Penelope D; Gamble, Matthew J et al. (2018) S100A4 regulates macrophage invasion by distinct myosin-dependent and myosin-independent mechanisms. Mol Biol Cell 29:632-642
Liu, Xia; Taftaf, Rokana; Kawaguchi, Madoka et al. (2018) Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models. Cancer Discov :
Nobre, Ana Rita; Entenberg, David; Wang, Yarong et al. (2018) The Different Routes to Metastasis via Hypoxia-Regulated Programs. Trends Cell Biol 28:941-956
Donnelly, Sara K; Miskolci, Veronika; Garrastegui, Alice M et al. (2018) Characterization of Genetically Encoded FRET Biosensors for Rho-Family GTPases. Methods Mol Biol 1821:87-106
Entenberg, David; Voiculescu, Sonia; Guo, Peng et al. (2018) A permanent window for the murine lung enables high-resolution imaging of cancer metastasis. Nat Methods 15:73-80
Norwood Toro, Laura E; Wang, Yarong; Condeelis, John S et al. (2018) Myosin-IIA heavy chain phosphorylation on S1943 regulates tumor metastasis. Exp Cell Res 370:273-282
Bresnick, Anne R (2018) S100 proteins as therapeutic targets. Biophys Rev 10:1617-1629
Suyama, Kimita; Yao, Jiahong; Liang, Huizhi et al. (2018) An Akt3 Splice Variant Lacking the Serine 472 Phosphorylation Site Promotes Apoptosis and Suppresses Mammary Tumorigenesis. Cancer Res 78:103-114
Pastoriza, Jessica M; Karagiannis, George S; Lin, Juan et al. (2018) Black race and distant recurrence after neoadjuvant or adjuvant chemotherapy in breast cancer. Clin Exp Metastasis 35:613-623

Showing the most recent 10 out of 234 publications